Converting enzyme inhibitors
Comparing the effect of Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in heart failure patients with type 2 diabetes mellitus: a systematic review
... angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in heart fail- ure patients with type 2 diabetes mellitus (Table ...
5
Underutilization of Angiotensin Converting Enzyme Inhibitors Among Heart Failure Patients
... There are well-established guidelines regarding the use of Angiotensin converting enzyme inhibitors (ACEI) in the management of heart failure (HF). In-spite of that, many studies has documented ...
6
ASSOCIATION OF ANGIOTENSIN I CONVERTING ENZYME INHIBITORS WITH THE ANGIOTENSIN II RECEPTORS ANTAGONISTS
... angiotensin- converting enzyme inhibitors are well known mainly in the hypertension and heart failure treatment ...ACE inhibitors and with ARB (angiotensin II receptor blocker) also called ...
5
EFFECT OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ON SERUM AMYLASE AND LIPASE IN PATIENTS WITH HYPERTENSION
... ace inhibitors causes an elevation in serum amylase and lipase levels 10 ...ace inhibitors usage was determined in hypertensive patients of both the groups, And it was found that factors like alcohol ...
5
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
... proton-pump inhibitors, medications for hypertension (including alpha-blockers, beta-blockers, calcium channel blockers, and diuretics), and medications for COPD including long-acting beta agonists, short-acting ...
8
The toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiae
... ACE inhibitors on ...water. Inhibitors dissolved in water were added separately to each well containing larvae to give a final concentration of 5 mM with Brewer’s yeast as the food ...
10
Angiotensin-converting enzyme inhibitors may affect pulmonary function in lymphangioleiomyomatosis
... angiotensin-converting enzyme (ACE) (expressed by the lungs), generating angiotensin II ...ACE inhibitors (ACEIs) is associated with a decreased risk of developing certain can- cers (6, 7), and slows ...
11
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
... Results: After adjusting for differences in covariates at baseline between the subjects who were prescribed ACEI N = 519 and ARB N = 182, as well as the associated odds of being prescrib[r] ...
6
Observational study of brain atrophy and cognitive decline comparing a sample of community dwelling people taking angiotensin converting enzyme inhibitors and angiotensin receptor blockers over time
... 896 (88) N/A 888 (83) 906 (88) 893 (86) 873 (75) n (%) n (%) n (%) n (%) n (%) n (%) Female sex 44 (55) 5 (4) 28 (60) 21 (45) 19 (54) 9 (75) ApoE4 carrier 17 (21) 4 (29) 11 (23) 10 (21) 8 (23) 3 (25) Type 2 diabetes 33 ...
28
<p>COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients</p>
... a rat model in 12-day treatment with drugs that either inhibit the synthesis of circulating Ang II or block the AT1 receptor, the therapy induced an increase in ACE2 heart mRNA, accompanied by an increase in ACE2 ...
10
“A Class Review on ACE Inhibitors/ARBS and Beta Blockers and Effectiveness in HFrEF” by Rakhi K R, Dhandapani Chidambaram, Aleena Alex, Ann Merry Davis, Bharathi K, Keerthanaa B, India.
... angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers and ...Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers, are ...
5
Early onset of graft glomerulopathy in a patient with post-transplant diabetes mellitus after renal transplantation: a case report
... Angiotensin-Converting Enzyme Inhibitors; ADA: American Diabetes Association; ARBs: Angiotensin II Receptor Blockers; BMI: Body Mass Index; CNI: Calcineurin Inhibitors; CyA: Cyclosporine; DN: ...
5
Memory is preserved in older adults taking AT1 receptor blockers
... Angiotensin-converting enzyme; ACEI: Angiotensin-converting enzyme inhibitors; ADNI: Alzheimer ’ s Disease Neuroimaging Initiative; ANOVA: Analysis of variance; APOE: Apolipoprotein E; ...
14
Hypertension resistant to antihypertensive agents commonly occurs with the progression of diabetic nephropathy in Japanese patients with type 2 diabetes mellitus: a prospective observational study
... angiotensin- converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) have vascular protective effects, especially in the patients with diabetic nephropa- thy [8-13], it is ...
6
Repurposing of approved cardiovascular drugs
... Research and development of new drugs requires both long time and high costs, whereas safety and tolerability profiles make the success rate of approval very low. Drug repurposing, applying known drugs and compounds to ...
15
Assessment of adverse drug reactions of angiotensin converting enzyme (ace) inhibitors and angiotensin receptor blockers (arbs) among sudanese patients
... Renin angiotensin aldosterone system inhibitor drugs such as ACEIs and ARBs are very useful in treatment of different diseases situation. However, most of the studies has been carried in countries other than Sudan. ...
5
The risks and benefits of patients temporarily discontinuing medications in the event of an intercurrent illness: a systematic review protocol
... angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, direct renin inhibitors, NSAIDs, metformin and sulfonylureas in at-risk patients experiencing an intercurrent illness ...
6
Higher reticulocyte counts are associated with higher mortality rates in hemodialysis patients: a retrospective single-center cohort study
... angiotensin- converting enzyme inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs), the use of intravenous iron injections during the week prior to enrollment, and the average weekly dose of ...
11
Potentially inappropriate medication use in nursing homes: an observational study using the NORGEP-NH criteria
... ACE-inhibitors: angiotensin-converting enzyme inhibitors; ADR: adverse drug reaction; ARB: angiotensin receptor blockers; AT2-antagonists: angiotensin II receptor antagonists; BPSD: Beha[r] ...
11
Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases
... angiotensin-converting enzyme inhibitors; ARBs: angiotensin-II receptor blockers; BNP: brain natriuretic peptide; CAD: coronary artery disease; CANVAS: CANagliflozin cardioVascular Assessment Study; ...
28